Division of Nephrology, Department of Internal Medicine, Soonchunhyang University College of Medicine, 170, Jomaru-ro, Bucheon 14584, Republic of Korea; Center for Medical Device Safety Information Monitoring, Soonchunhyang University Bucheon Hospital, 170, Jomaru-ro, Bucheon 14584, Republic of Korea.
Department of Medical Engineering, Dongguk University College of Medicine, 27, Dongguk-ro, Ilsandong-gu, Goyang 10326, Republic of Korea; Center for Medical Device Safety Information Monitoring, Dongguk University Ilsan Hospital, 27, Dongguk-ro, Ilsandong-gu, Goyang 10326, Republic of Korea.
Health Policy. 2021 Jul;125(7):941-946. doi: 10.1016/j.healthpol.2021.04.017. Epub 2021 May 4.
Medical devices may revolutionize healthcare delivery but can lead to serious adverse events for treated patients and users. While reporting of adverse events related to medical devices is an essential starting point for post-market surveillance, underreporting of medical device adverse events is a global problem. Korea introduced a voluntary medical device adverse event reporting system in 2010, called the Medical Device Safety Information Monitoring Center, which has led to an increase in adverse event reports. For 10 years, the Medical Device Safety Information Monitoring Center has analyzed medical device adverse events systematically and has provided active feedback to the manufacturers and education on safe use. Recently, the Medical Device Safety Information Monitoring Center contributed to harmonization of international medical device vigilance through the sharing of adverse events. This experience of Korea might contribute to improvements in medical device vigilance, which is a critical prerequisite for improving medical device policies and regulations.
医疗器械可能会彻底改变医疗服务的提供方式,但也可能给接受治疗的患者和使用者带来严重的不良事件。虽然医疗器械不良事件报告是上市后监测的一个重要起点,但医疗器械不良事件的报告不足是一个全球性问题。韩国于 2010 年引入了一个自愿医疗器械不良事件报告系统,称为医疗器械安全信息监测中心,该系统促使医疗器械不良事件报告数量有所增加。十年来,医疗器械安全信息监测中心系统地分析医疗器械不良事件,并向制造商提供积极的反馈和安全使用教育。最近,医疗器械安全信息监测中心通过不良事件的共享,为国际医疗器械警戒工作的协调做出了贡献。韩国的这一经验可能有助于提高医疗器械警戒水平,这是改善医疗器械政策和法规的关键前提。